Collaborating to Advance

Rapid Biomarker-Based Diagnostics

Galaxy CCRO works with established industry, clinical, and academic partners to accelerate biomarker discovery, clinical validation, manufacturing readiness, and global deployment. These collaborations enable rapid translation of scientific innovation into practical, real-world diagnostic solutions.

NG Biotech Log no background

NG Biotech

Rapid Diagnostic Manufacturing & Global Distribution

NG Biotech is an ISO 13485–certified developer and manufacturer of rapid diagnostic tests, founded by pioneers of the point-of-care testing industry. The company operates a proprietary, patented immunoassay platform capable of producing qualitative and multiplex diagnostics from a single drop of blood in minutes.

With CE-marked products distributed worldwide and a production capacity exceeding 4 million tests per month, NG Biotech supports Galaxy CCRO across assay development, manufacturing scale-up, and international market access.

Focus Areas

  • Point-of-care immunoassay platforms
  • Large-scale manufacturing
  • Product registration and commercialization
  • Global diagnostics distribution

🔗 https://www.ngbiotech.com/

Proteome Sciences Logo

Proteome Sciences

Advanced Proteomics & Biomarker Discovery

Proteome Sciences is a leader in mass-spectrometry–based proteomics, supporting biomarker discovery, validation, and translational research. Their proprietary workflows and analytical expertise are widely used across clinical research, pharmaceutical development, and diagnostics.

Proteome Sciences supports Galaxy CCRO in the identification, confirmation, and analytical characterization of biomarker candidates across neurological, oncologic, and systemic injury applications.

Focus Areas

  • Mass spectrometry proteomics
  • Biomarker discovery and validation
  • Translational research support

🔗 https://www.proteomics.com/

Randox Logo

Randox

Assay Development & Clinical Diagnostics Expertise

Randox is a global diagnostics company specializing in clinical chemistry, immunoassay development, and laboratory diagnostics. With decades of experience supporting healthcare systems worldwide, Randox brings deep expertise in assay development, analytical performance, and laboratory validation.

Randox contributes domain expertise relevant to clinical diagnostics, assay benchmarking, and comparative performance evaluation.

Focus Areas

  • Clinical diagnostics
  • Assay development
  • Laboratory reference methods

🔗 https://www.randox.com/

NHS Logo

Queen Elizabeth University Hospital (Glasgow)

Academic Clinical Validation Partner

Queen Elizabeth University Hospital is one of Europe’s largest acute care teaching hospitals and a major center for neurological, emergency, and critical care medicine. As part of NHS Greater Glasgow and Clyde, the hospital supports advanced clinical research and evaluation of emerging diagnostic technologies.

The institution collaborates with Galaxy CCRO on clinical evaluation and pilot studies in real-world acute care settings.

Focus Areas

  • Acute neurology and emergency medicine
  • Clinical research and validation
  • Academic hospital trials

🔗 https://www.nhsggc.scot/hospitals-services/main-hospitals/queen-elizabeth/

Physicians Premier logo

Physicians PremiER

Emergency Medicine Clinical Network

Physicians PremiER is a physician-owned emergency medicine group providing clinical services across multiple emergency departments. The organization emphasizes evidence-based practice and clinical quality in community and hospital-based emergency care.

Physicians PremiER supports Galaxy CCRO through access to frontline clinical environments and practitioner insight relevant to emergency diagnostic workflows.

Focus Areas

  • Emergency medicine clinical sites
  • Workflow evaluation
  • Clinician feedback and usability

🔗 https://mdpremier.com/

Abilene Christian University Logo

Abilene Christian University (ACU)

Academic Research & Translational Collaboration

Abilene Christian University supports interdisciplinary research spanning biomedical science, engineering, and data analytics. Through academic collaboration, ACU contributes to early-stage research, translational studies, and workforce development.

ACU supports Galaxy CCRO through applied research initiatives and academic collaboration across biomarker science and diagnostic innovation.

Focus Areas

  • Academic research
  • Translational science
  • Education and innovation partnerships

🔗 https://acu.edu/

Partner With Us

Galaxy CCRO collaborates with organizations advancing diagnostics, biomarker science, and clinical decision support. We welcome discussions with partners interested in research collaboration, clinical evaluation, manufacturing, distribution, and translational deployment.

If your organization is exploring opportunities in point-of-care diagnostics, biomarker platforms, or applied clinical innovation, we invite you to connect.